Tumor Thermosensitive Embolic Agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tumor Thermosensitive Embolic Agent, covering 2026-01-21 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer [NA]